Long-Term Assets: The sum of all assets classified as non-current.
Moleculin Biotech, Inc. (MBRX) had Long-Term Assets of $12.40M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-14.61M |
|
-- |
|
-- |
|
$7.87M |
|
$-7.87M |
|
$-4.97M |
|
$-12.85M |
|
$-12.85M |
|
$-12.85M |
|
$-12.85M |
|
$-12.85M |
|
$-12.85M |
|
$-7.87M |
|
$-7.87M |
|
4.12M |
|
4.12M |
|
$-3.54 |
|
$-3.54 |
|
| Balance Sheet Financials | |
$10.96M |
|
$0.07M |
|
|
Long-Term Assets |
$12.40M |
$23.36M |
|
$7.96M |
|
-- |
|
$0.22M |
|
$8.18M |
|
$15.18M |
|
$4.04M |
|
$15.18M |
|
5.34M |
|
| Cash Flow Statement Financials | |
$-6.11M |
|
-- |
|
$7.61M |
|
$8.88M |
|
$10.32M |
|
$1.44M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-84.60% |
|
-318.34% |
|
-54.98% |
|
-84.60% |
|
$2.85 |
|
$-1.48 |
|
$-1.48 |
|